Literature DB >> 23334129

Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.

Kimiteru Ito1, Miyako Morooka, Osamu Okazaki, Ryogo Minaminoto, Kazuo Kubota, Michiaki Hiroe.   

Abstract

A 65-year-old woman with a complete atrioventricular block was diagnosed as having cardiac sarcoidosis. (18)F-FDG PET/CT imaging without unfractionated heparin loading revealed systemic abnormal uptake indicating sarcoidosis. However, the cardiac lesions were vague because of the physiological FDG uptake. One month later, (18)F-FDG PET/CT using heparin loading was performed to evaluate the lesion activity prior to the start of steroid administration. (18)F-FDG PET/CT imaging with heparin loading showed the cardiac lesions more clearly and suppressed the FDG uptake in normal myocardium. Heparin loading during FDG PET/CT may be useful for detecting cardiac involvement in patients with cardiac sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23334129     DOI: 10.1097/RLU.0b013e318266cb25

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  9 in total

1.  Optimizing radionuclide imaging in the assessment of cardiac sarcoidosis.

Authors:  John P Bois; Panithaya Chareonthaitawee
Journal:  J Nucl Cardiol       Date:  2015-08-13       Impact factor: 5.952

2.  Continuing evolution in preparation protocols for 18FDG PET assessment of inflammatory or malignant myocardial disease.

Authors:  John P Bois; Panithaya Chareonthaitawee
Journal:  J Nucl Cardiol       Date:  2016-03-25       Impact factor: 5.952

3.  Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET/MR imaging.

Authors:  Felix Nensa; E Tezgah; K Schweins; J Goebel; P Heusch; K Nassenstein; T Schlosser; T D Poeppel
Journal:  J Nucl Cardiol       Date:  2016-03-18       Impact factor: 5.952

4.  Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis.

Authors:  Lars C Gormsen; Nana Louise Christensen; Elisabeth Bendstrup; Lars Poulsen Tolbod; Søren Steen Nielsen
Journal:  J Nucl Cardiol       Date:  2013-10-17       Impact factor: 5.952

5.  Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.

Authors:  Constantin Lapa; Theresa Reiter; Malte Kircher; Andreas Schirbel; Rudolf A Werner; Theo Pelzer; Carmen Pizarro; Dirk Skowasch; Lena Thomas; Ulrike Schlesinger-Irsch; Daniel Thomas; Ralph A Bundschuh; Wolfgang R Bauer; Florian C Gärtner
Journal:  Oncotarget       Date:  2016-11-22

Review 6.  Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation.

Authors:  Malte Kircher; Constantin Lapa
Journal:  Curr Cardiovasc Imaging Rep       Date:  2017-02-10

7.  The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis.

Authors:  Osamu Manabe; Keiichiro Yoshinaga; Hiroshi Ohira; Atsuro Masuda; Takahiro Sato; Ichizo Tsujino; Asuka Yamada; Noriko Oyama-Manabe; Kenji Hirata; Masaharu Nishimura; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2015-08-05       Impact factor: 5.952

8.  Novel imaging strategies for the detection of prosthetic heart valve obstruction and endocarditis.

Authors:  W Tanis; R P J Budde; I A C van der Bilt; B Delemarre; G Hoohenkerk; J-K van Rooden; A M Scholtens; J Habets; S Chamuleau
Journal:  Neth Heart J       Date:  2016-02       Impact factor: 2.380

9.  Fluorine-18 fluorodeoxyglucose positron emission tomography for cardiac sarcoidosis-is it time to consider a new radiotracer?

Authors:  Georgios Christopoulos; Panithaya Chareonthaitawee
Journal:  EJNMMI Res       Date:  2017-08-29       Impact factor: 3.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.